Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Ryo Tajiri"'
Autor:
Yuki Kurihara, Hiroki Tashiro, Koichiro Takahashi, Ryo Tajiri, Yuki Kuwahara, Kokoro Kajiwara, Natsuko Komiya, Shinsuke Ogusu, Chiho Nakashima, Tomomi Nakamura, Shinya Kimura, Naoko Sueoka‐Aragane
Publikováno v:
Thoracic Cancer, Vol 13, Iss 24, Pp 3459-3466 (2022)
Abstract Background Transbronchial biopsy (TBB) with endobronchial ultrasonography and a guide sheath (EBUS‐GS) is an effective examination tool for the diagnosis of lung cancer. Factors related to making the diagnosis are still not fully understoo
Externí odkaz:
https://doaj.org/article/38204ae12a7642fdbc2c3fb279351a4d
Autor:
Hiroki Tashiro, Koichiro Takahashi, Yuki Kurihara, Hironori Sadamatsu, Yuki Kuwahara, Ryo Tajiri, Shinya Kimura, Naoko Sueoka-Aragane
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Obesity is associated with the severity of asthma, which is characterized by airway obstruction. Pulmonary function testing is one of the important examinations for evaluating airway obstruction. However, the impact of obesity on pulmonary f
Externí odkaz:
https://doaj.org/article/8749e7c4808c43249501ad35941ee3ca
Autor:
Hirokazu Takahashi, Takaomi Kessoku, Miwa Kawanaka, Michihiro Nonaka, Hideyuki Hyogo, Hideki Fujii, Tomoaki Nakajima, Kento Imajo, Kenichi Tanaka, Yoshihito Kubotsu, Hiroshi Isoda, Satoshi Oeda, Osamu Kurai, Masato Yoneda, Masafumi Ono, Yoichiro Kitajima, Ryo Tajiri, Ayako Takamori, Atsushi Kawaguchi, Shinichi Aishima, Masayoshi Kage, Atsushi Nakajima, Yuichiro Eguchi, Keizo Anzai
Publikováno v:
Hepatology Communications, Vol 6, Iss 1, Pp 120-132 (2022)
Sodium glucose cotransporter‐2 inhibitors (SGLT2is) are now widely used to treat diabetes, but their effects on nonalcoholic fatty liver disease (NAFLD) remain to be determined. We aimed to evaluate the effects of SGLT2is on the pathogenesis of NAF
Externí odkaz:
https://doaj.org/article/5dd1cff1eff446b8b6f5d7c3c17859ed
Autor:
Hiroki Tashiro, Koichiro Takahashi, Masahide Tanaka, Hironori Sadamatsu, Yuki Kurihara, Ryo Tajiri, Ayako Takamori, Hiroyuki Naotsuka, Hiroki Imaizumi, Shinya Kimura, Naoko Sueoka-Aragane
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Decreasing exercise tolerance is one of the key features related to a poor prognosis in patients with chronic obstructive pulmonary disease (COPD). Cardiopulmonary exercise testing (CPET) is useful for evaluating exercise tolerance. The pres
Externí odkaz:
https://doaj.org/article/1f774f051a054d059561f0d22b63adeb
Autor:
Hiroki Tashiro, Yuki Kurihara, Koichiro Takahashi, Hironori Sadamatsu, Tetsuro Haraguchi, Ryo Tajiri, Ayako Takamori, Shinya Kimura, Naoko Sueoka-Aragane
Publikováno v:
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Exacerbations are critical events in chronic pulmonary obstructive disease (COPD). The frequency of COPD exacerbations is associated with the prognosis, including mortality, but no useful biomarker has been established. Methods Th
Externí odkaz:
https://doaj.org/article/3a86dd0d6edb4d7aa572aae0c5aa9fa3
Clinical impact of advanced chronic kidney disease in patients with non-HIV pulmonary cryptococcosis
Autor:
Hiroki Tashiro, Tetsuro Haraguchi, Koichiro Takahashi, Hironori Sadamatsu, Ryo Tajiri, Ayako Takamori, Shinya Kimura, Naoko Sueoka-Aragane
Publikováno v:
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-6 (2020)
Abstract Background Pulmonary cryptococcosis is an uncommon infectious disease that can develop in both immunocompromised and immunocompetent patients. The severity of chronic kidney disease (CKD) was reported to be one of the risk factors for pulmon
Externí odkaz:
https://doaj.org/article/499c6cf2cccc4ce8ab44272deb335385
Autor:
Tomoaki Nakajima, Keizo Anzai, Atsushi Kawaguchi, Osamu Kurai, Yoshihito Kubotsu, Ayako Takamori, Hirokazu Takahashi, Michihiro Nonaka, Hideyuki Hyogo, Masafumi Ono, Satoshi Oeda, Miwa Kawanaka, Yuichiro Eguchi, Kenichi Tanaka, Kento Imajo, Masato Yoneda, Masayoshi Kage, Shinichi Aishima, Takaomi Kessoku, Yoichiro Kitajima, Ryo Tajiri, Atsushi Nakajima, Hiroshi Isoda, Hideki Fujii
Publikováno v:
Hepatology Communications, Vol 6, Iss 1, Pp 120-132 (2022)
Hepatology Communications
Hepatology Communications
Sodium glucose cotransporter‐2 inhibitors (SGLT2is) are now widely used to treat diabetes, but their effects on nonalcoholic fatty liver disease (NAFLD) remain to be determined. We aimed to evaluate the effects of SGLT2is on the pathogenesis of NAF
Autor:
Naoyuki OTANI, Masayuki SHIOZAKI, Kana HISAMOTO, Fumitaka MIZUKI, Hiroyuki ARAKI, Ryo TAJIRI, Mieko INADA, Noriko HIDA, Etsuko ARITA, Yasuko MATSUNO, Shoji SANADA
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 52:165-173
Autor:
Makoto Yoshida, Atsushi Kawaguchi, Naoko Sueoka-Aragane, Ayako Takamori, Shinichiro Hayashi, Hiroki Tashiro, Takashi Kinoshita, Hiroshi Inoue, Keisuke Kojima, Ryo Tajiri, Koichiro Takahashi, Go Kato, Tomotaka Kawayama, Masahide Tanaka, Shinya Kimura, Hiromi Kobayashi, Masaru Uchida, Hironori Sadamatsu
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Background Comparative effects on physical activity of mono and dual bronchodilators remain unclear in patients with treatment-naive chronic obstructive pulmonary disease (COPD). We sought to compare the changes in physical activity before and after
Autor:
Koichiro Takahashi, Hiroki Tashiro, Ryo Tajiri, Ayako Takamori, Masaru Uchida, Go Kato, Yuki Kurihara, Hironori Sadamatsu, Takashi Kinoshita, Makoto Yoshida, Atsushi Kawaguchi, Shinya Kimura, Naoko Sueoka-Aragane, Tomotaka Kawayama
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Koichiro Takahashi,1 Hiroki Tashiro,1 Ryo Tajiri,2 Ayako Takamori,2 Masaru Uchida,3 Go Kato,4 Yuki Kurihara,1 Hironori Sadamatsu,1 Takashi Kinoshita,5 Makoto Yoshida,6 Atsushi Kawaguchi,2,7 Shinya Kimura,1 Naoko Sueoka-Aragane,1 Tomotaka Kawayama5 On